<DOC>
	<DOCNO>NCT00264147</DOCNO>
	<brief_summary>To assess clinically active dose range study medication treatment patient rheumatoid arthritis .</brief_summary>
	<brief_title>Rheumatoid Arthritis Dose Ranging Study ( 0663-086 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Patient diagnose rheumatoid arthritis ( RA ) least 6 month prior otherwise judge general good health currently take nonsteroidal antiinflammatory drug ( NSAIDS ) treat his/her RA symptom Patient need stop take medication order participate , continue take his/her antirheumatic medication long stable certain period time Patients disease medical condition ( ) could worsen interfere evaluation effectiveness study medication allow participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Arcoxia</keyword>
</DOC>